Background
AGS Beer’s criteria 2015 1) | STOPP/START v2 2015 2) | JGS STOPP-J 2015 3) | |
---|---|---|---|
Latest version Developed | AGS | Study group at University College Cork | JGS |
Original version (year, developer) | 1991, Dr. Beers | 2008, Study group at University College Cork | 2005, JGS |
Target population | United States; 65 and older; Ambulatory, acute, and institutionalized settings | Europe-wide prescribing practices;65 and older; in most clinical settings | Japan; 75 and older; 74 and younger with frailty; 65 and older in need of nursing care; chronic treatment |
Therapeutic category / drug | 26 potentially inappropriate medication (PIM) 12 PIM due to drug-disease/ drug-syndrome interactions 5 PIM to be used with caution 10 PIM non-anti-infective drug-drug interactions that should be avoided in older adults | 80 criteria in STOPP 34 criteria in START | 29 groups for drugs to be prescribed with special caution 8 groups for drugs to consider starting |
Remarks | Supplement information: “Quality of evidence” and “Strength of Recommendation” | For adverse drug events prevention and cost reduction | Supplement information: “Quality of evidence” and “Strength of Recommendation” |
Methods
Process for listing drug substances
Listing drugs | - Listed JGS substances were limited to those approved as medicinal product for oral use in Japan, except insulin. - Listed JGS substances were prescribed for long-term use in general. - If a combination drug is comprised with more than one of listed therapeutic category, combinations were presented in Table 5. |
---|---|
Coding with ATC | - If ATC codes at the 5th level cannot be directly matched to the substance, an alternate 4th level code is proposed by searching online [1]. - The 5th level ATC code is proposed when it is available for the combination, otherwise ATC codes are searched for each substance. - ATC codes for topical use were excluded |
Coding with Japan code | - Some vaccines are not available because vaccine is not covered by the pricing list for the national health insurance but by other public support. - The pricing list is available for medicinal products currently in the market. |
Drug classification systems
Results
Therapeutic category/JAN English name | Japan 2) | ATC3) |
---|---|---|
Nervous system: Overall antipsychotic drugs - Antipsychotic drugs | ||
Aripiprazole Hydrate | 1179045 | N05AX12 |
Asenapine Maleate | 1179056 | N05AH05 |
Blonanserin | 1179048 | N05AX |
Bromperidol | 1179028 | N05 AD06 |
Chlorpromazine Hydrochloride | 1171001 | N05AA01 |
Chlorpromazine Phenolphthalinate | 1171005 | N05AA01 |
Clocapramine Hydrochloride Hydrate | 1179030 | N05AX |
Clozapine | 1179049 | N05AH02 |
Fluphenazine Maleate | 1172009 | N05AB02 |
Haloperidol | 1179020 | N05 AD01 |
Levomepromazine Maleate | 1172014 | N05AA02 |
Mosapramine Hydrochloride | 1179035 | N05AX10 |
Nemonapride | 1179036 | N05AL |
Olanzapine | 1179044 | N05AH03 |
Oxypertine | 1179011 | N05AE01 |
Paliperidone | 1179053 | N05AX13 |
Perphenazine | 1172006 1172007 | N05AB03 |
Perphenazine Fendizoate | 1172004 | N05AB03 |
Perphenazine Maleate | 1172013 | N05AB03 |
Perospirone Hydrochloride Hydrate | 1179043 | N05AX |
Pimozide | 1179022 | N05AG02 |
Pipamperone Hydrochloride | 1179006 | N05 AD05 |
Prochlorperazine Maleate | 1172010 | N05AB04 |
Propericiazine (Periciazine) | 1172005 | N05 AC01 |
Quetiapine Fumarate | 1179042 | N05AH04 |
Risperidone | 1179038 | N05AX08 |
Spiperone | 1179015 | N05 AD |
Sulpiride | 1179016 2329009 | N05AL01 |
Sultopride Hydrochloride | 1179032 | N05AL02 |
Tiapride Hydrochloride | 1190004 | N05AL03 |
Timiperone | 1179026 | N05 AD |
Zotepine | 1179024 | N05AX11 |
Combination (see Table 5) | ||
Nervous system: Benzodiazepines | ||
Alprazolam | 1124023 | N05BA12 |
Bromazepam | 1124020 | N05BA08 |
Brotizolam | 1124009 | N05CD09 |
Chlordiazepoxide | 1124028 | N05BA02 |
Clorazepate Dipotassium | 1124015 | N05BA05 |
Clotiazepam | 1179012 | N05BA21 |
Cloxazolam | 1124014 | N05BA22 |
Diazepam | 1124017 | N05BA01 |
Estazolam | 1124001 | N05CD04 |
Ethyl Loflazepate | 1124029 | N05BA18 |
Etizolam | 1179025 | N05BA19 |
Fludiazepam | 1124019 | N05BA17 |
Flunitrazepam | 1124008 | N05CD03 |
Flurazepam Hydrochloride | 1124002 | N05CD01 |
Flutazolam | 1124024 | N05BA |
Flutoprazepam | 1124027 | N05BA |
Haloxazolam | 1124005 | N05CD |
Lorazepam | 1124022 | N05BA06 |
Lormetazepam | 1124010 | N05CD06 |
Medazepam | 1124021 | N05BA03 |
Mexazolam | 1124025 | N05BA |
Nimetazepam | 1124004 | N05BA |
Nitrazepam | 1124003 | N05CD02 |
Oxazolam | 1124013 | N05BA |
Quazepam | 1124030 | N05CD10 |
Rilmazafone Hydrochloride Hydrate | 1129006 | N05CD |
Tofisopam | 1124026 | N05BA23 |
Triazolam | 1124007 | N05CD05 |
Nervous system: Non-benzodiazepines | ||
Eszopiclone | 1129010 | N05CF04 |
Zolpidem Tartrate | 1129009 | N05CF02 |
Zopiclone | 1129007 | N05CF01 |
Nervous system: Tricyclic antidepressants | ||
Amitriptyline Hydrochloride | 1179002 | N06AA09 |
Amoxapine | 1179001 | N06AA17 |
Clomipramine Hydrochloride | 1174002 | N06AA04 |
Dosulepin Hydrochloride | 1179027 | N06AA16 |
Imipramine Hydrochloride | 1174006 | N06AA02 |
Lofepramine Hydrochloride | 1174004 | N06AA07 |
Nortriptyline Hydrochloride | 1179004 | N06AA10 |
Trimipramine Maleate | 1174005 | N06AA06 |
Nervous system: Selective serotonin reuptake inhibitor (SSRI) | ||
Escitalopram Oxalate | 1179054 | N06AB10 |
Fluvoxamine Maleate | 1179039 | N06AB08 |
Paroxetine Hydrochloride Hydrate | 1179041 | N06AB05 |
Sertraline Hydrochloride | 1179046 | N06AB06 |
Nervous system: Antiparkinsonian drugs – Anticholinergic drugs | ||
Biperiden Hydrochloride | 1162001 | N04AA02 |
Mazaticol Hydrochloride Hydrate | 1169004 | N04AA10 |
Piroheptine Hydrochloride | 1169003 | N04AA |
Profenamine Hibenzate | 1163002 | N04AA05 |
Profenamine Hydrochloride | 1163001 | N04AA05 |
Promethazine Hydrochloride | 4413002 | R06AD02 D04AA10 |
Promethazine Hibenzate | 4413002 | R06AD02 D04AA10 |
Promethazine Methylenedisalicylate | 4413002 | R06AD02 D04AA10 |
Trihexyphenidyl Hydrochloride | 1169001 1169002 | N04AA01 |
Systemic hormonal preparations, excl. Sex hormones and insulins: Oral corticosteroids | ||
Betamethasone | 2454004 | H02AB01 |
Cortisone Acetate | 2452001 | H02AB10 |
Dexamethasone | 2454002 | D07AB19 H02AB02 |
Hydrocortisone | 2452002 | H02AB09 |
Methylprednisolone | 2456003 | H02AB04 |
Prednisolone | 2456001 2456002 | H02AB06 |
Triamcinolone | 2454003 | H02AB08 |
Combination (see Table 5) | ||
Blood and blood forming organs: Antithrombotic drugs | ||
Acetylsalicylic acid (Aspirin) | 1143001 3399007 | N02BA01 B01AC06 |
Apixaban | 3339004 | B01AF02 |
Cilostazol | 3399002 | B01AC23 |
Clopidogrel Sulfate | 3399008 | B01AC04 |
Dabigatran Etexilate Methanesulfonate | 3339001 | B01AE07 |
Edoxaban Tosilate Hydrate | 3339002 | B01AF03 |
Prasugrel Hydrochloride | 3399009 | B01AC22 |
Rivaroxaban | 3339003 | B01AF01 |
Ticlopidine Hydrochloride | 3399001 | B01AC05 |
Ticagrelor | 3399011 | B01AC24 |
Warfarin potassium | 3332001 | B01AA03 |
Combination (see Table 5) | ||
Cardiovascular system: Digitalis | ||
Digoxin | 2113003 2113004 | C01AA05 |
Metildigoxin | 2113005 | C01AA08 |
Cardiovascular system: High-ceiling diuretics | ||
Azosemide | 2139008 | C03CA |
Bumetanide | 2139004 | C03CA02 |
Furosemide | 2139005 | C03CA01 |
Piretanide | 2139007 | C03CA03 |
Torasemide | 2139009 | C03CA04 |
Cardiovascular system: Potassium-sparing agents | ||
Eplerenone | 2149045 | C03DA04 |
Spironolactone | 2133001 | C03DA01 |
Cardiovascular system: Beta blocking agents | ||
Alprenolol Hydrochloride | 2123002 | C07AA01 |
Arotinolol Hydrochloride | 2123014 | C07AA |
Bufetolol Hydrochloride | 2123006 | C07AA |
Carteolol Hydrochloride | 2123005 2149025 | C07AA15 S01ED05 |
Nadolol | 2123015 | C07AA12 |
Nipradilol | 2149021 | C07AA S01ED |
Pindolol | 2123009 2149011 | C07AA03 |
Propranolol Hydrochloride | 2123008 2149014 | C07AA05 |
Cardiovascular system: Alpha1 blocking agents | ||
Bunazosin Hydrochloride | 2149015 | C02CA |
Doxazosin Mesilate | 2149026 | C02CA04 |
Prazosin Hydrochloride | 2149002 | C02CA01 |
Terazosin Hydrochloride Hydrate | 2149023 | G04CA03 |
Urapidil | 2149020 | C02CA06 |
Respiratory system: H1 receptor antagonists (1st generation) | ||
Alimemazine Tartrate | 4413003 | R06AD01 |
Chlorpheniramine Maleate | 4419001 4419003 | R06AB04 |
Clemastine Fumarate | 4419008 | R06AA04 |
Cyproheptadine Hydrochloride Hydrate | 4419005 | R06AX02 |
D-chlorpheniramine Maleate | 4419002 | R06AB04 |
Diphenhidramine | 4411001 | R06AA02 |
Homochlorcyclizine Hydrochloride | 4419006 | R06AE |
Hydroxyzine Hydrochloride | 1179005 | N05BB01 |
Hydroxyzine Pamoate | 1179019 | N05BB01 |
Promethazine Hibenzate (relisted) | 4413002 | R06AD02 |
Promethazine Hydrochloride (relisted) | 4413002 | R06AD02 |
Promethazine Methylenedisalicylate (relisted) | 4413002 | R06AD02 |
Combination (see Table 5) | ||
Alimentary tract and metabolism: H2 receptor antagonists | ||
Cimetidine | 2325001 | A02BA01 |
Famotidine | 2325003 | A02BA03 |
Lafutidine | 2325006 | A02BA08 |
Nizatidine | 2325005 | A02BA04 |
Ranitidine Hydrochloride | 2325002 | A02BA02 |
Roxatidine Acetate Hydrochloride | 2325004 | A02BA06 |
Alimentary tract and metabolism: Antiemetic agents | ||
Metoclopramide | 2399004 | A03FA01 |
Promethazine Hibenzate (relisted) | 4413002 | R06AD02 D04AA10 |
Promethazine Hydrochloride (relisted) | 4413002 | R06AD02 D04AA10 |
Promethazine Methylenedisalicylate (relisted) | 4413002 | R06AD02 D04AA10 |
Alimentary tract and metabolism: Drugs for constipation | ||
Magnesium Oxide | 2344002 2344009 | A02AA02 A06AD02 |
Alimentary tract and metabolism: Biguanides | ||
Buformin Hydrochloride | 3962001 | A10BA03 |
Metformin Hydrochloride | 3962002 | A10BA02 |
Combination (see Table 5) | ||
Alimentary tract and metabolism: sulfonylureas | ||
Acetohexamide | 3961001 | A10BB31 |
Chlorpropamide | 3961004 | A10BB02 |
Glibenclamide | 3961003 | A10BB01 |
Gliclazide | 3961007 | A10BB09 |
Glimepiride | 3961008 | A10BB12 |
Glyclopyramide | 3961002 | A10BB |
Tolbutamide | 3961006 | A10BB03 |
Combination (see Table 5) | ||
Alimentary tract and metabolism: Alpha glucosidase inhibitors | ||
Acarbose | 3969003 | A10BF01 |
Miglitol | 3969009 | A10BF02 |
Voglibose | 3969004 | A10BF03 |
Combination (see Table 5) | ||
Alimentary tract and metabolism: Thiazoridinediones | ||
Pioglitazone Hydrochloride | 3969007 | A10BG03 |
Combination (see Table 5) | ||
Alimentary tract and metabolism: Sodium-glucose co-transporter 2 (SGLT2) inhibitors | ||
Canagliflozin Hydrate | 3969022 | A10BK02 |
Dapagliflozin Propylene Glycolate Hydrate | 3969019 | A10BK01 |
Empagliflozin | 3969023 | A10BK03 |
Ipragliflozin L-proline | 3969018 | A10BK |
Luseogliflozin Hydrate | 3969020 | A10BK |
Tofogliflozin Hydrate | 3969021 | A10BK |
Urologicals: Muscarinic receptor antagonists | ||
Fesoterodine Fumarate | 2590015 | G04BD11 |
Imidafenacin | 2590013 | G04BD |
Oxybutynin Hydrochloride | 2590005 | G04BD04 |
Propiverine Hydrochloride | 2590007 | G04BD06 |
Solifenacin Succinate | 2590011 | G04BD08 |
Tolterodine Tartrate | 2590012 | G04BD07 |
Musculo-skeletal system: Non-steroidal antiinflammatory drugs (NSAIDs) | ||
Acemetacin | 1145003 | M01AB11 |
Amfenac Sodium Hydrate | 1147006 | M01AB |
Ampiroxicam | 1149030 | M01 AC |
Acetylsalicylic acid (Aspirin) (relisted) | 1143001 3399007 | N92BA01 B01AC06 |
Bucolome | 1149009 | M01AX |
Diclofenac Sodium | 1147002 | M01AB05 S01 BC03 M02AA15 |
Emorfazone | 1148004 | N02BG |
Etodolac | 1149032 | M01AB08 |
Flufenamate Aluminum | 1141004 | M01AG03 |
Flurbiprofen | 1149011 | M01AE09 M02AA19 |
Ibuprofen | 1149001 | M01AE01 |
Indometacin | 1145001 1145002 | C01EB03 M01AB01 M02AA23 |
Indomethacin Farnesil | 1145005 | M01AB01 |
Lornoxicam | 1149036 | M01 AC05 |
Loxoprofen Sodium Hydrate | 1149019 | M01AE M02AA |
Mefenamic Acid | 1141005 | M01AG01 |
Meloxicam | 1149035 | M01 AC06 |
Mofezolac | 1149033 | M01AX |
Nabumetone | 1149027 | M01AX01 |
Naproxen | 1149007 | M01AE02 |
Oxaprozin | 1149026 | M01AE12 |
Piroxicam | 1149017 | M01 AC01 M02AA07 S01 BC06 |
Pranoprofen | 1149010 | S01 BC09 |
Proglumetacin Maleate | 1145004 | M01AB14 |
Sulindac | 1149015 | M01AB02 |
Tiaprofenic Acid | 1149025 | M01AE11 |
Tiaramide Hydrochloride | 1148001 | N02BG |
Zaltoprofen | 1149029 | M01AE |
Combination (See Table 5) |
Therapeutic category/JAN English name | Japan 2) | ATC 2) |
---|---|---|
Antiparkinson drugs | ||
Combination (see Table 5) | ||
Vaccine: Influenza | ||
Influenza HA Vaccine (A/B) | NA | J07BB02 |
Adsorbed Influenza Virus Vaccine (H5N1) | NA | J07BB02 |
Vaccine: Pneumococcal | ||
Pneumococcal Polysaccharide Conjugate Vaccine(adsorbed) | 631140G | J07AL52 |
Pneumococcus Vaccine | 6311400 | J07AL01 |
Cardiovascular system: Angiotensin conversion enzyme (ACE) inhibitor | ||
Alacepril | 2144003 | C09AA |
Benazepril Hydrochloride | 2144007 | C09AA07 |
Captopril | 2144001 | C09AA01 |
Cilazapril Hydrate | 2144005 | C09AA08 |
Delapril Hydrochloride | 2144004 | C09AA12 |
Enalapril Maleate | 2144002 | C09AA02 |
Imidapril Hydrochloride | 2144008 | C09AA16 |
Lisinopril Hydrate | 2144006 | C09AA03 |
Perindopril Erbumine | 2144012 | C09AA04 |
Quinapril Hydrochloride | 2144010 | C09AA06 |
Temocapril Hydrochloride | 2144009 | C09AA14 |
Trandolapril | 2144011 | C09AA10 |
Cardiovascular system: Angiotensin receptor blocker (ARB) | ||
Azilsartan | 2149048 | C09CA09 |
Candesartan Cilexetil | 2149040 | C09CA06 |
Irbesartan | 2149046 | C09CA04 |
Olmesartan Medoxomil | 2149044 | C09CA08 |
Telmisartan | 2149042 | C09CA07 |
Valsartan | 2149041 | C09CA03 |
Losartan Potassium | 2149039 | C09CA01 |
Coombination (See Table 5) | ||
Cardiovascular system: Lipid modifying agents (Statine) | ||
Atorvastatin Calcium Hydrate | 2189015 | C10AA05 |
Fluvastatin Sodium | 2189012 | C10AA04 |
Pitavastatin Calcium Hydrate | 2189016 | C10AA08 |
Pravastatin Sodium | 2189010 | C10AA03 |
Rosuvastatin Calcium | 2189017 | C10AA07 |
Simvastatin | 2189011 | C10AA01 |
Coombination (See Table 5) | ||
Urologicals: Drugs for benign prostatic hypertrophy (selective alpha-1 blockers) | ||
Naftopidil | 2590009 | G04CA |
Silodosin | 2590010 | G04CA04 |
Tamsulosin Hydrochloride | 2590008 | G04CA02 |
Antineoplastic and immunomodulating agents: Drugs for rheumatoid arthritis | ||
Actarit | 1149031 | M01CX |
Auranofin | 4420001 | M01CB03 |
Bucillamine | 4420002 | M01CC02 |
Iguratimod | 3999031 | M01CX |
Leflunomide | 3999020 | L04AA13 |
Lobenzarit Sodium | 1149020 | M01CX |
Methotrexate | 4222001 3999016 | L01BA01 L04AX03 |
Mizoribine | 3999002 | L04AX |
Salazosulfapyridine | 6219001 | A07EC01 |
Tofacitinib Citrate | 3999034 | L04AA29 |
Combination drugs (substance name in JAN) | Japan 1) | ATC2) |
---|---|---|
“List of drugs to be prescribed with special caution” | ||
Chlorpromazine Hydrochloride Phenobarbital * Promethazine Hydrochloride | 1179100 1179101 | R06AD52 promethazine, combinations or N05AA01 chlorpromazine and R06AD02 promethazine |
tia Aluminum Glycinate * Magnesium Carbonate * | 1143010 3399100 | N02BA51 acetylsalicylic acid, combinations excl. Psycholeptics |
Acetylsalicylic acid (aspirin) Clopidogrel Sulfate | 3399101 | N02BA51 acetylsalicylic acid, combinations excl. Psycholeptics or B01AC06 acetylsalicylic acid and B01AC04 clopidogrel |
Acetylsalicylic acid (aspirin) Lansoprazole * | 3399102 | B01AC56 acetylsalicylic acid, combinations with proton pump inhibitors |
Metformin Hydrochloride Pioglitazone Hydrochloride | 3969100 | A10BD05 metformin and pioglitazone |
Glimepiride Pioglitazone Hydrochloride | 3969101 | A10BD06 glimepiride and pioglitazone |
Mitiglinide Voglibose | 3969102 | A10BD Combinations of oral blood glucose lowering drugs or A10BX08 mitiglinide and A10BF03 voglibose |
Pioglitazone Alogliptin* | 3969103 | A10BD09 pioglitazone and alogliptin |
Metformin Vildagliptin* | 3969104 | A10BD08 metformin and vildagliptin |
Alogliptin* Metformin | 3969105 | A10BD13 metformin and alogliptin |
“List of drugs to consider starting” | ||
Entacapone * Carbidopa Hydrate Levodopa | 1169102 | N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor |
Carbidopa Hydrate * Levodopa | 1169101 | N04BA02 levodopa and decarboxylase inhibitor |
Benserazide Hydrochloride * Levodopa | 1169100 | N04BA02 levodopa and decarboxylase inhibitor |
Azilsartan Amlodipine Besilate | 2149121 | C09CA09 azilsartan medoxomil and C08CA01 amlodipine |
Azelnidipine Olmesartan Medoxomil | 2149115 | C08C selective calcium channel blockers with mainly vascular effects and C09CA08 olmesartan medoxomil |
Amlodipine Besilate Irbesartan | 2149118 | C09DB05 irbesartan and amlodipine |
Amlodipine Besilate Candesartan Cilexetil | 2149116 | C09DB07 candesartan and amlodipine |
Amlodipine Besilate Telmisartan | 2149117 | C09DB04 telmisartan and amlodipine |
Amlodipine Besilate Valsartan | 2149114 | C09DB01 valsartan and amlodipine |
Irbesartan Trichlormethiazide | 2149119 | C09DA04 irbesartan and diuretics |
Candesartan Cilexetil Hydrochlorothiazide | 2149111 | C09DA06 candesartan and diuretics |
Cilnidipine Valsartan | 2149120 | C08CA14 cilnidipine and C09CA03 valsartan |
Termisartan Hydrochlorothiazide | 2149113 | C09DA07 telmisartan and diuretics |
Valsartan Hydrochlorothiazide | 2149112 | C09DA03 valsartan and diuretics |
Hydrochlorothiazide Losartan Potassium | 2149110 | C09DA01 losartan and diuretics |
Atorvastatin Calcium Hydrate Amlodipine Besilate | 2190101 2190102 2190103 2109104 | C10BX03 atorvastatin and amlodipine |